128 related articles for article (PubMed ID: 12857926)
1. Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin.
Okuma K; Dalton KP; Buonocore L; Ramsburg E; Rose JK
J Virol; 2003 Aug; 77(15):8562-9. PubMed ID: 12857926
[TBL] [Abstract][Full Text] [Related]
2. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
3. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins.
Buonocore L; Blight KJ; Rice CM; Rose JK
J Virol; 2002 Jul; 76(14):6865-72. PubMed ID: 12072487
[TBL] [Abstract][Full Text] [Related]
4. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles.
Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140
[TBL] [Abstract][Full Text] [Related]
5. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
Kahn JS; Schnell MJ; Buonocore L; Rose JK
Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
[TBL] [Abstract][Full Text] [Related]
8. Organization of the vesicular stomatitis virus glycoprotein into membrane microdomains occurs independently of intracellular viral components.
Brown EL; Lyles DS
J Virol; 2003 Apr; 77(7):3985-92. PubMed ID: 12634358
[TBL] [Abstract][Full Text] [Related]
9. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
Guibinga GH; Miyanohara A; Esko JD; Friedmann T
Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
[TBL] [Abstract][Full Text] [Related]
10. A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.
Delebecque F; Pramberger K; Prévost MC; Brahic M; Tangy F
J Virol; 2002 Aug; 76(15):7883-9. PubMed ID: 12097602
[TBL] [Abstract][Full Text] [Related]
11. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly.
Robison CS; Whitt MA
J Virol; 2000 Mar; 74(5):2239-46. PubMed ID: 10666254
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1.
Rose NF; Roberts A; Buonocore L; Rose JK
J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984
[TBL] [Abstract][Full Text] [Related]
13. Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding.
Klenk K; Roberts SR
Virus Res; 2002 Dec; 90(1-2):327-35. PubMed ID: 12457986
[TBL] [Abstract][Full Text] [Related]
14. Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells.
Zimmer G; Zimmer KP; Trotz I; Herrler G
J Virol; 2002 Apr; 76(8):4103-7. PubMed ID: 11907250
[TBL] [Abstract][Full Text] [Related]
15. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus.
Schnell MJ; Buonocore L; Boritz E; Ghosh HP; Chernish R; Rose JK
EMBO J; 1998 Aug; 17(5):1289-96. PubMed ID: 9482726
[TBL] [Abstract][Full Text] [Related]
16. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
[TBL] [Abstract][Full Text] [Related]
17. Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell line.
Gao Y; Whitaker-Dowling P; Watkins SC; Griffin JA; Bergman I
J Virol; 2006 Sep; 80(17):8603-12. PubMed ID: 16912309
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in mice.
Zhang M; Ge J; Li X; Chen W; Wang X; Wen Z; Bu Z
Virol J; 2016 Feb; 13():31. PubMed ID: 26911572
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
20. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors.
Schneider M; Graham FL; Prevec L
J Gen Virol; 1989 Feb; 70 ( Pt 2)():417-27. PubMed ID: 2543746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
